Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Response to radiation.

K E Rosenzweig1, J L Fox, P Giraud

  • 1Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. rosenzwk@mskc.org

Seminars in Radiation Oncology
|November 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coriolis and centrifugal forces drive haltere deformations and influence spike timing.

Journal of the Royal Society, Interface·2019
Same author

Radiation therapy for malignant pleural mesothelioma.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2017
Same author

Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane.

International journal of pharmaceutical compounding·2013
Same author

Stability of albuterol in continuous nebulization.

International journal of pharmaceutical compounding·2013
Same author

Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.

International journal of pharmaceutical compounding·2013
Same author

A study of respiration-correlated cone-beam CT scans to correct target positioning errors in radiotherapy of thoracic cancer.

Medical physics·2012
Same journal

Integrative Medicine for Breast Cancer Survivors.

Seminars in radiation oncology·2026
Same journal

Integrative Oncology Approaches for Gastrointestinal Symptoms and Risk Reduction in Patients With Digestive Tract Cancers.

Seminars in radiation oncology·2026
Same journal

Integrative Oncology and Radiation Therapy: An Essential Evolution.

Seminars in radiation oncology·2026
Same journal

Clinical Trials of Integrative Oncology Interventions for Radiation Therapy: Emerging Evidence and Opportunities.

Seminars in radiation oncology·2026
Same journal

Nonpharmacologic Approaches for Pain Management in Patients With Cancer Treated With Radiation Therapy.

Seminars in radiation oncology·2026
Same journal

Integrative Therapies for Radiation-Related Toxicities in Hematological Malignancies.

Seminars in radiation oncology·2026
See all related articles

18F-fluoro-2-deoxy-glucose positron emission tomography (FDG-PET) offers significant advantages over traditional computed tomography (CT) for non-small cell lung cancer (NSCLC) management. FDG-PET enhances diagnosis, staging, treatment planning, and response assessment in NSCLC patients.

Area of Science:

  • Oncology
  • Radiology
  • Nuclear Medicine

Background:

  • Computed tomography (CT) is the standard for diagnosing and monitoring non-small cell lung cancer (NSCLC).
  • CT has limitations in fully assessing NSCLC, prompting investigation into advanced imaging techniques.
  • 18F-fluoro-2-deoxy-glucose positron emission tomography (FDG-PET) has emerged as a promising complementary tool.

Purpose of the Study:

  • To review the diverse applications of FDG-PET in NSCLC diagnosis and management.
  • To highlight the clinical data supporting FDG-PET's utility in NSCLC.
  • To discuss future directions for FDG-PET in NSCLC care.

Main Methods:

  • Review of clinical data on FDG-PET applications in NSCLC.
  • Comparison of FDG-PET findings with traditional CT imaging.

Related Experiment Videos

  • Evaluation of FDG-PET's role in diagnosis, staging, treatment planning, and response assessment.

    • Main Results:

    • FDG-PET is well-established as an adjunct to CT for NSCLC diagnosis and staging.
    • FDG-PET improves precision in lesion definition for radiation treatment planning.
    • Emerging evidence supports FDG-PET's value in assessing clinical response during and after NSCLC treatment.

    Conclusions:

    • FDG-PET offers significant advantages over CT for NSCLC management.
    • FDG-PET plays a crucial role in enhancing diagnostic accuracy, treatment precision, and response evaluation.
    • Further research into FDG-PET applications holds promise for advancing NSCLC patient care.